共查询到20条相似文献,搜索用时 15 毫秒
1.
Plazak W Gryga K Dziedzic H Tomkiewicz-Pajak L Konieczynska M Podolec P Musial J 《Arthritis research & therapy》2011,13(4):R117
Introduction
Mortality in systemic lupus erythematosus (SLE) patients is influenced by an increased occurrence of severe cardiovascular complications. Statins have been proven to protect a wide spectrum of SLE patients from these complications. This study was conducted to determine the possible efficacy of atorvastatin in SLE patients as assessed by multi-detector computed tomography (MDCT)-based coronary calcium scoring and single photon emission computed tomography (SPECT) of the myocardium. 相似文献2.
Hooi-Ming Lee Toru Mima Hidehiko Sugino Chieko Aoki Yasuo Adachi Naoko Yoshio-Hoshino Kenichi Matsubara Norihiro Nishimoto 《Arthritis research & therapy》2009,11(1):R1-10
Introduction
Systemic lupus erythematosus (SLE) is a prototypical autoimmune disease characterized by various clinical manifestations. Several cytokines interact and play pathological roles in SLE, although the etiopathology is still obscure. In the present study we investigated the network of immune response-related molecules expressed in the peripheral blood of SLE patients, and the effects of cytokine interactions on the regulation of these molecules. 相似文献3.
Juan Du Min Li Denghai Zhang Xiaoyan Zhu Weiwei Zhang Wei Gu Yinglu Feng Xiaofeng Zhai Changquan Ling 《Arthritis research & therapy》2009,11(4):R108
Introduction
Glucocorticoid (GC) therapy is the main treatment for systemic lupus erythematosus (SLE). However, some patients are resistant to these agents. Abnormalities of glucocorticoid receptor (GR) seem to be related to steroid resistance. This study evaluated GRs in T lymphocytes and monocytes of SLE patients by flow cytometry (FCM) using a monoclonal antibody (mAb) and FITC-Dex probes. 相似文献4.
Eriksson C Kokkonen H Johansson M Hallmans G Wadell G Rantapää-Dahlqvist S 《Arthritis research & therapy》2011,13(1):R30
Introduction
Autoantibodies have a central role in systemic lupus erythematosus (SLE). The presence of autoantibodies preceding disease onset by years has been reported both in patients with SLE and in those with rheumatoid arthritis, suggesting a gradual development of these diseases. Therefore, we sought to identify autoantibodies in a northern European population predating the onset of symptoms of SLE and their relationship to presenting symptoms. 相似文献5.
Mandana Nikpour Dafna D Gladman Dominique Ibanez Paula J Harvey Murray B Urowitz 《Arthritis research & therapy》2010,12(3):R125
Introduction
Total cholesterol (TC) and blood pressure (BP) are likely to take a dynamic course over time in patients with systemic lupus erythematosus (SLE). This would have important implications in terms of using single-point-in-time measurements of these variables to assess coronary artery disease (CAD) risk. The objective of this study was to describe and quantify variability over time of TC and BP among patients with SLE and to determine their correlates. 相似文献6.
Beatriz Rodríguez-Bayona Ana Ramos-Amaya José J Pérez-Venegas Carmen Rodríguez José A Brieva 《Arthritis research & therapy》2010,12(3):R108
Introduction
Systemic lupus erythematosus (SLE) is characterized by B cell hyper-activation and auto-reactivity resulting in pathogenic auto-antibody generation. The phenotypic analysis of blood B cell subsets can be used to understand these alterations. 相似文献7.
Introduction
Systemic lupus erythematosus (SLE) is a prototypical autoimmune disease characterized by various systemic symptoms and multiple organ damage. We clarify biological and functional abnormalities in SLE by comparing the gene expression profiles of SLE patients with those of healthy individuals. 相似文献8.
Chang-Hee Suh Brendan Hilliard Sophia Li Joan T Merrill Philip L Cohen 《Arthritis research & therapy》2010,12(4):R146
Introduction
The TAM (tyro 3, axl, mer) kinases are key regulators of innate immunity and are important in the phagocytosis of apoptotic cells. Gas6 and protein S are ligands for these TAM kinases and bind to phosphatidyl serine residues exposed during apoptosis. In animal models, absence of TAM kinases is associated with lupus-like disease. To test whether human systemic lupus erythematosus (SLE) patients might have deficient levels of TAM ligands, we measured Gas 6 and protein S levels in SLE. 相似文献9.
10.
Guillermo Ruiz-Irastorza Nerea Olivares Ioana Ruiz-Arruza Agustin Martinez-Berriotxoa Maria-Victoria Egurbide Ciriaco Aguirre 《Arthritis research & therapy》2009,11(4):R109-8
Introduction
Infections commonly complicate the course of systemic lupus erythematosus (SLE). Our aim is to investigate the clinical predictors of major infections in patients with SLE. 相似文献11.
Introduction
Previous studies have shown that traditional risk factors such as hypercholesterolemia and hypertension account for only a small proportion of the dramatically increased risk of atherosclerotic coronary artery disease (CAD) in systemic lupus erythematosus (SLE). However, in these studies, exposure to risk factors was measured only at baseline. In this study, our objective was to compare measures of cumulative exposure with remote and recent values for each of total cholesterol (TC), systolic (SBP), and diastolic (DBP) blood pressure in terms of ability to quantify risk of atherosclerotic CAD in patients with SLE. 相似文献12.
Ou Jin Sushma Kavikondala Mo-Yin Mok Lingyun Sun Jieruo Gu Rong Fu Albert Chan Joseph Yeung Yingjie Nie Chak-Sing Lau 《Arthritis research & therapy》2010,12(4):R137-11
Introduction
Dendritic cells (DCs) are capable of inducing immunity or tolerance. Previous studies have suggested plasmacytoid DCs (pDCs) are pathogenic in systemic lupus erythematosus (SLE). However, the functional characteristics of directly isolated peripheral circulating blood pDCs in SLE have not been evaluated previously. 相似文献13.
Seung-Ki Kwok June-Yong Lee Se-Ho Park Mi-La Cho So-Youn Min Sung-Hwan Park Ho-Youn Kim Young-Gyu Cho 《Arthritis research & therapy》2008,10(2):R29
Background
It is well known that interferon (IFN)-α is important to the pathogenesis of systemic lupus erythematosus (SLE). However, several reports have indicated that the number of IFN-α producing cells are decreased or that their function is defective in patients with SLE. We studied the function of plasmacytoid dendritic cells (pDCs) under persistent stimulation of Toll-like receptor (TLR)9 via a TLR9 ligand (CpG ODN2216) or SLE serum. 相似文献14.
Dolff S Abdulahad WH Westra J Doornbos-van der Meer B Limburg PC Kallenberg CG Bijl M 《Arthritis research & therapy》2011,13(5):R157
Introduction
Systemic lupus erythematosus (SLE) is an autoimmune disease accompanied by a disturbed T-cell balance skewed towards effector T-cells, in particular Th17-cells. The novel cytokine interleukin-21 (IL-21) is suggested to be crucial for triggering T-cell responses towards IL-17 producing cells. Thus, we aimed to investigate the ability of T-cells to produce IL-21 and IL-17 in SLE patients. 相似文献15.
Chih Long Liu Stephanie Tangsombatvisit Jacob M Rosenberg Gil Mandelbaum Emily C Gillespie Or P Gozani Ash A Alizadeh Paul J Utz 《Arthritis research & therapy》2012,14(1):R25-14
Introduction
Autoreactivity to histones is a pervasive feature of several human autoimmune disorders, including systemic lupus erythematosus (SLE). Specific post-translational modifications (PTMs) of histones within neutrophil extracellular traps (NETs) may potentially drive the process by which tolerance to these chromatin-associated proteins is broken. We hypothesized that NETs and their unique histone PTMs might be capable of inducing autoantibodies that target histones. 相似文献16.
Sebastian Dolff Daniel Quandt Benjamin Wilde Thorsten Feldkamp Fan Hua Xin Cai Christof Specker Andreas Kribben Cees GM Kallenberg Oliver Witzke 《Arthritis research & therapy》2010,12(4):R150
Introduction
There is growing evidence that interleukin 17 (IL-17) producing T cells are involved in the pathogenesis of systemic lupus erythematosus (SLE). Previous studies showed that increased percentages of T-cell subsets expressing the costimulatory molecules CD80 and CD134 are associated with disease activity and renal involvement in SLE. The aim of this study was to investigate the distribution and phenotypical characteristics of IL-17 producing T-cells in SLE, in particular in patients with lupus nephritis, with emphasis on the expression of CD80 and CD134. 相似文献17.
Djabarouti S Breilh D Duffau P Lazaro E Greib C Caubet O Saux MC Pellegrin JL Viallard JF 《Arthritis research & therapy》2010,12(6):R217
Introduction
The aim of this study was to determine whether mycophenolate mofetil (MMF) pharmacokinetics (PK) under combined MMF and prednisone remission-maintenance therapy can predict systemic lupus erythematosus (SLE) clinical flares. 相似文献18.
Silvia N Kariuki Beverly S Franek Akaash A Kumar Jasmine Arrington Rachel A Mikolaitis Tammy O Utset Meenakshi Jolly Mary K Crow Andrew D Skol Timothy B Niewold 《Arthritis research & therapy》2010,12(4):R151
Introduction
Systemic lupus erythematosus (SLE) is a highly heterogeneous disorder, characterized by differences in autoantibody profile, serum cytokines, and clinical manifestations. SLE-associated autoantibodies and high serum interferon alpha (IFN-α) are important heritable phenotypes in SLE which are correlated with each other, and play a role in disease pathogenesis. These two heritable risk factors are shared between ancestral backgrounds. The aim of the study was to detect genetic factors associated with autoantibody profiles and serum IFN-α in SLE. 相似文献19.
Katarina Almehed Szabolcs Hetényi Claes Ohlsson Hans Carlsten Helena Forsblad-d'Elia 《Arthritis research & therapy》2010,12(4):R153
Introduction
Our objective was to determine the frequency of and factors associated with prevalent vertebral compression fractures in female systemic lupus erythematosus (SLE) patients attending rheumatologists in western Sweden. 相似文献20.